Orchid Pharma reports consolidated net profit of Rs 28.59 crore in the September 2026 quarter

Sales rise 14.34% to Rs 341.27 crore

Net profit of Orchid Pharma reported to Rs 28.59 crore in the quarter ended September 2026 as against net loss of Rs 0.90 crore during the previous quarter ended September 2025. Sales rose 14.34% to Rs 341.27 crore in the quarter ended September 2026 as against Rs 298.46 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	341.27	298.46	14
OPM %	7.07	1.03	-
PBDT	38.25	12.15	215
PBT	26.84	1.34	1903
NP	28.59	-0.90	LP

Powered by Capital Market - Live News